CoChat
Cited by 72

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

MUC1 oncoprotein is a druggable target in human prostate cancer cells

Open access
Joshi, Maya Datt, Ahmad, Rehan, Yin, Li, Raina, Deepak, Rajabi, Hasan, Bubley, Glenn, Kharbanda, Surender, Kufe, Donald · 2009 · Molecular Cancer Therapeutics

Abstract

Human prostate cancers are dependent on the androgen receptor for their progression. The MUC1 heterodimeric oncoprotein is aberrantly overexpressed in prostate cancers; however, it is not known if MUC1 is of functional importance to these tumors. To assess dependence on MUC1, we synthesized an inhibitor, designated GO-201, which interacts directly with the MUC1-C subunit at its oligomerization domain. Treatment of MUC1-positive DU145 and PC3 prostate cancer cells with GO-201, and not an altered version, resulted in inhibition of proliferation. GO-201 also induced necrotic cell death that was associated with increases in reactive oxygen species, loss of mitochondrial transmembrane potential, and depletion of ATP. By contrast, GO-201 had no effect against MUC1-negative LNCaP, CWR22Rv1, and MDA-PCa-2b prostate cancer cells. Significantly, GO-201 treatment of DU145 and PC3 xenografts growing in nude mice resulted in complete tumor regression and prolonged lack of recurrence. These findings indicate that certain prostate cancer cells are dependent on MUC1-C for growth and survival and that directly targeting MUC1-C results in their death in vitro and in tumor models. [Mol Cancer Ther 2009;8(11):3056–65]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1535-7163.mct-09-0646

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 72

Metadata

Authors
Joshi, M. D., Ahmad, R., Yin, L., Raina, D., Rajabi, H., Bubley, G., Kharbanda, S., & Kufe, D.
Venue
Molecular Cancer Therapeutics
Published
2009-11-01
Volume
8
Issue
11
Pages
3056-3065
ISSN
  • 1535-7163 (ISSN-L)
  • 1538-8514
OpenAlex
W2118642421
Cited by
72
References
7
FWCI
5.84
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MUC1 oncoprotein is a druggable target in human prostate cancer cells. https://app.cochat.ai/papers/10.1158/1535-7163.mct-09-0646
The paper
Joshi, M. D., Ahmad, R., Yin, L., Raina, D., Rajabi, H., Bubley, G., Kharbanda, S., & Kufe, D. (2009). MUC1 oncoprotein is a druggable target in human prostate cancer cells. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-09-0646

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.